Ignelzi Troy A. — SEC Form 4 filings
SEC reporting owner CIK 1579829. 9 Form 4 filings on record with FilingPulse; latest filed 2026-06-26.
Transaction summary — filings shown
Covers all 9 filings on record, filed 2024-05-20 to 2026-06-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 1 filing — 10,000 shares, $100,988 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 8.
- Largest priced transaction: purchase of 9,900 shares @ $10.10 ($99,990) in Rapport Therapeutics, Inc., filed 2025-03-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Rapport Therapeutics, Inc. (RAPP) | Chief Financial Officer | 4 | 2 legs · 10,000 sh · $100,988 | — | 3 |
| Contineum Therapeutics, Inc. (CTNM) | Director | 4 | — | — | 4 |
| Harmony Biosciences Holdings, Inc. (HRMY) | Director | 1 | — | — | 1 |
Form 4 filings — Ignelzi Troy A.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-26 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 19,000 (derivative) @ $0 | EDGAR |
| 2026-04-06 | 4 | Harmony Biosciences Holdings, Inc. (HRMY) | Grant/award (A): 17,710 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 148,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 14,750 (derivative) @ $0 | EDGAR |
| 2025-03-13 | 4 | Rapport Therapeutics, Inc. (RAPP) | Purchase (P): 9,900 @ $10.10 · Purchase (P): 100 @ $9.98 | EDGAR |
| 2025-02-04 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 142,000 (derivative) @ $0 | EDGAR |
| 2024-06-10 | 4 | Rapport Therapeutics, Inc. (RAPP) | Grant/award (A): 81,366 (derivative) @ $0 | EDGAR |
| 2024-05-29 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 6,350 (derivative) @ $0 | EDGAR |
| 2024-05-20 | 4 | Contineum Therapeutics, Inc. (CTNM) | Grant/award (A): 23,150 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1579829 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →